C » Topics » (d) Statutory Leave of Absence.

This excerpt taken from the C 10-K filed Feb 26, 2010.
(c) Statutory Leave of Absence. The Award will continue to vest during a leave of absence that is approved by management of Participant’s business unit, is provided by applicable law and taken in accordance with such law and applicable Company policy (a “statutory leave of absence”). If a statutory leave of absence is followed without interruption by an approved personal leave of absence, any unvested shares will be canceled as of the date that the combined leaves, if continuous, have exceeded six months. If the employment of Participant terminates for any reason during an approved statutory leave of absence, then such applicable provisions of this Section 6 will apply.
 
     
This excerpt taken from the C 10-Q filed Nov 6, 2009.
(d) Statutory Leave of Absence.  The Award will continue to vest [and Participant may continue to exercise vested Option shares (but not later than the Option expiration date)] during a leave of absence that is approved by management of Participant’s business unit, is provided by applicable law and taken in accordance with such law and applicable Company policy (a “statutory leave of absence”).  If a statutory leave of absence is followed without interruption by an approved personal leave of absence, any unvested [restricted or deferred stock [and [unvested][unexercised] Option shares]][deferred cash award] will be canceled as of the date that the combined leaves, if continuous, have exceeded six months.  If Participant terminates employment for any reason during an approved statutory leave of absence[, or if on or prior to such time Participant satisfies the conditions of Section 6(j), (k), or (l)], then such applicable provisions of this Section 6 will apply.  [For purposes of Section 6(j), (k) and (l), if a statutory leave of absence is followed without interruption by an approved personal leave of absence, Participant’s employment will be deemed to have terminated as of the date that the combined leaves exceed six months.]

 

These excerpts taken from the C 8-K filed Jan 21, 2009.
(d) Statutory Leave of Absence.  Participation in the Program will continue during a leave of absence that is approved by management of Participant’s business unit, is provided by applicable law and taken in accordance with such law and applicable Company policy (a “statutory leave of absence”).  If a statutory leave of absence is followed without interruption by an approved personal leave of absence, any unvested portion of the Award will be canceled as of the date that the combined leaves, if continuous, have exceeded six months.  Any previously vested shares, and accrued dividend equivalents, if applicable (less appropriate withholdings for the payment of taxes), will be distributed to Participant on the 30th day after the Award Termination Date.

(d) Statutory Leave of Absence.  The Option will continue to vest and Participant may continue to exercise vested Option shares (but not later than the Option expiration date), subject to satisfaction of the Grant Price Exercise Condition, during a leave of absence that is approved by management of Participant’s business unit, is provided by applicable law and taken in accordance with such law and applicable Company policy (a “statutory leave of absence”).  If a statutory leave of absence is followed without interruption by an approved personal leave of absence, any unvested Option shares will be canceled as of the date that the combined leaves, if continuous, have exceeded six months, but vested Option shares may be exercised, subject to satisfaction of the Grant Price Exercise Condition, until no later than the Option expiration date.

This excerpt taken from the C 10-Q filed Oct 31, 2008.
(d) Statutory Leave of Absence.  The Award will continue to vest [and Participant may continue to exercise vested Option shares (but not later than the Option expiration date)] during a leave of absence that is approved by management of Participant’s business unit, is provided by applicable law and taken in accordance with such law and applicable Company policy (a “statutory leave of absence”).  If a statutory leave of absence is followed without interruption by an approved personal leave of absence, any unvested restricted or deferred stock [and unexercised Option shares][deferred cash award] will be canceled as of the date that the combined leaves, if continuous, have exceeded six months.  If Participant terminates employment for any reason during an approved statutory leave of absence[, or if on or prior to such time Participant satisfies the conditions of Section 6(j), (k), or (l)], then such applicable provisions of this Section 6 will apply.  [For purposes of Section 6(j), (k) and (l), if a statutory leave of absence is followed without interruption by an approved personal leave of absence, Participant’s employment will be deemed to have terminated as of the date that the combined leaves exceed six months.]

 

This excerpt taken from the C 10-Q filed Aug 3, 2007.
(d)           Statutory Leave of Absence.  The Award will continue to vest during an approved family medical leave or maternity leave of absence (under the Family Medical Leave Act of 1993 in the United States), military leave or other statutory leave of absence, provided that such leave is approved by management of Participant’s business unit, is provided by applicable law and is taken in accordance with such law and applicable Company policy (a “statutory leave of absence”).  If a statutory leave of absence is followed without interruption by an approved personal leave of absence, the Award will be canceled as of the date that the combined leaves have exceeded six months if (i) such date occurs prior to the Vesting Date and (ii) the statutory leave of absence ended prior to the Vesting Date.  If Participant’s employment terminates for any reason during an approved statutory leave of absence, then the applicable subsection of this Section 3 will apply.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki